STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLMT
  4. [Form 4/A] Calumet, Inc. /DE Amended Insider Trading Activity

Calumet director exercises RSUs and sells shares

Calumet, Inc. director Daniel J. Sajkowski reported an exercise of 5,053 Restricted Stock Units into an equal number of shares of common stock on December 4, 2025, followed by a sale of 2,022 shares of common stock the same day.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Calumet, Inc. director Daniel J. Sajkowski reported an exercise of 5,053 Restricted Stock Units into an equal number of shares of common stock on December 4, 2025, followed by a sale of 2,022 shares of common stock the same day. The filing notes that each RSU is the economic equivalent of one Calumet common share and may be settled in stock or cash, and that the reporting person elected to have a portion of vested RSUs settled in cash. After these transactions, Sajkowski holds 85,268 shares of Calumet common stock directly.

Positive

  • None.

Negative

  • None.
Insider Sajkowski Daniel J
Role Director
Sold 2,022 shs ($0.00)
Approx. gross sale proceeds $0.00
Approx. exercise cost $0.00
Type Security Shares Price Value
Exercise Restricted Stock Unit 5,053 $0.00 $0.00
Exercise Common Stock, par value $0.01 per share 5,053 $0.00 $0.00
Sale Common Stock, par value $0.01 per share 2,022 $0.00 $0.00
Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Common Stock, par value $0.01 per share — 85,268 shares (Direct)
Footnotes (3)
  1. F1. The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share.
  2. F2. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
  3. F3. Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.
RSUs Exercised 5,053 units Restricted Stock Units converted into common stock on December 4, 2025
Underlying Shares from RSUs 5,053 shares Common stock received upon RSU exercise, each RSU equal to one share
Shares Sold 2,022 shares Non-derivative sale of Calumet common stock on December 4, 2025
Post-transaction Holdings 85,268 shares Direct ownership of Calumet common stock after reported transactions
RSUs Settled in Cash 40% Portion of vested RSUs elected for cash settlement per footnote
Restricted Stock Unit financial
"The reporting person elected to receive 40% of Restricted Stock Units vested"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
economic equivalent financial
"Each Restricted Stock Unit is the economic equivalent of one share of Calumet"
cash equivalent financial
"to be settled in the cash equivalent of a Calumet, Inc. common share"
par value $0.01 per share financial
"Common Stock, par value $0.01 per share"
100% vested financial
"Restricted Stock Units are 100% vested"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock transactions did CLMT director Daniel Sajkowski report?
Daniel J. Sajkowski reported converting 5,053 Restricted Stock Units into common shares and then selling 2,022 Calumet (CLMT) shares on December 4, 2025. The RSUs are fully vested and economically equal to Calumet common stock.

How many Calumet (CLMT) shares did Sajkowski sell in this filing?
Sajkowski reported a sale of 2,022 shares of Calumet, Inc. common stock. This transaction occurred on December 4, 2025 and was reported as a non-derivative sale of common stock under transaction code S.

How many CLMT shares does Sajkowski hold after these transactions?
After the reported exercise and sale, Sajkowski directly holds 85,268 shares of Calumet, Inc. common stock. This post-transaction holding is reported as a direct ownership position in the filing’s canonical holdings data.

What Restricted Stock Units did Calumet (CLMT) report for Sajkowski?
The filing shows 5,053 Restricted Stock Units for Sajkowski, each the economic equivalent of one common share of Calumet. Footnotes state these RSUs are 100% vested and payable in stock or the cash value thereof.

Did Sajkowski elect cash settlement for any RSUs in the CLMT filing?
Yes. A footnote states Sajkowski elected to receive 40% of the vested Restricted Stock Units reported to be settled in the cash equivalent of a Calumet, Inc. common share, rather than in shares of common stock.

What is the overall direction of Sajkowski’s CLMT transactions?
The overall direction is net-sell. He exercised 5,053 RSUs into common stock and sold 2,022 shares, with the transaction summary showing net sell shares of 2,022 for Calumet, Inc. (CLMT).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sajkowski Daniel J
(Last) (First) (Middle)
1060 N CAPITOL AVE
SUITE 6-401
(Street)
INDIANAPOLIS IN 46204
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
12/05/2025 		6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 12/04/2025 M 5,053 A $0 87,290 D
Common Stock, par value $0.01 per share 12/04/2025 S 2,022(1) D $0 85,268 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (2) 12/04/2025 M 5,053 (3) (3) Common Stock, par value $0.01 per share 5,053 $0 0 D
Explanation of Responses:
1. The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share.
2. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
3. Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.
/s/ Connor J. Egan, as attorney-in-fact 02/26/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on CLMT

Trending in the feed

Open the live feed